Femara 2.5 mg Film Coated Tablet

*
Pharmacy Only: Prescription
  • Company:

    Novartis Ireland Limited
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 03 October 2024

File name

Femara REGSPC PF 24-0089_July 2024_clean.pdf

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 20 August 2021

File name

IPHA Femara REGPIL PF 20-0131_Jan_2021_Clean.pdf

Reasons for updating

  • Correction of spelling/typing errors

Updated on 25 February 2021

File name

IPHA Femera REGPIL PF 20-0131-Clean Feb 2021 (003).pdf

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 25 February 2021

File name

Femara REGSPC PF 20-0131 Clean Feb 2021.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 12 May 2020

File name

IPHA Femara2.5mgFilCoatedTablets_REGPIL_Clean Jan 2020.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 27 November 2019

File name

IPHA_Femara2.5mgFilCoatedTablets_PIL PF19-0205 Nov 2019_Clean.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 27 November 2019

File name

Femara REGSPC PF 19-0205 October 2019_Clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 09 May 2019

File name

Femara 2.5mg FCT 2220784_IE_p2_LFT_X-4 RA reviewed 04.03.2019_IPHA.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 22 March 2019

File name

Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 22 January 2019

File name

Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 24 July 2018

File name

Femara REGSPC_Clean July 2018.pdf

Reasons for updating

  • Change to MA holder contact details

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 July 2018

File name

Femara REGSPC_Clean July 2018.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2015

File name

PIL_8509_495.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 September 2015

Reasons for updating

  • Addition of information on reporting a side effect.

Updated on 23 April 2014

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 21 December 2012

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to how the medicine works

Updated on 14 April 2009

Reasons for updating

  • Change to information about pregnancy or lactation
  • Change to side-effects

Updated on 05 September 2008

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications

Updated on 30 January 2007

Reasons for updating

  • Change due to harmonisation of patient information leaflet

Updated on 29 August 2006

Reasons for updating

  • Change to, or new use for medicine

Updated on 16 May 2005

Reasons for updating

  • Change to, or new use for medicine

Updated on 25 August 2004

Reasons for updating

  • New PIL for medicines.ie